Cargando…

The hypoxia marker CAIX is prognostic in the UK phase III VorteX-Biobank cohort: an important resource for translational research in soft tissue sarcoma

BACKGROUND: Despite high metastasis rates, adjuvant/neoadjuvant systemic therapy for localised soft tissue sarcoma (STS) is not used routinely. Progress requires tailoring therapy to features of tumour biology, which need exploration in well-documented cohorts. Hypoxia has been linked to metastasis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Forker, Laura, Gaunt, Piers, Sioletic, Stefano, Shenjere, Patrick, Potter, Robert, Roberts, Darren, Irlam, Joely, Valentine, Helen, Hughes, David, Hughes, Ana, Billingham, Lucinda, Grimer, Rob, Seddon, Beatrice, Choudhury, Ananya, Robinson, Martin, West, Catharine M L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2018
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846059/ https://www.ncbi.nlm.nih.gov/pubmed/29235571 http://dx.doi.org/10.1038/bjc.2017.430

Ejemplares similares

Technical development and validation of a clinically applicable microenvironment classifier as a biomarker of tumour hypoxia for soft tissue sarcoma
por: Forker, Laura J., et al.
Publicado: (2023)

Validation of a hypoxia related gene signature in multiple soft tissue sarcoma cohorts
por: Yang, Lingjian, et al.
Publicado: (2017)

Correction: Validation of a hypoxia related gene signature in multiple soft tissue sarcoma cohorts
por: Yang, Lingjian, et al.
Publicado: (2019)

Selection of endogenous control genes for normalising gene expression data derived from formalin-fixed paraffin-embedded tumour tissue
por: Smith, Tim A. D., et al.
Publicado: (2020)

A miRNA signature predicts benefit from addition of hypoxia-modifying therapy to radiation treatment in invasive bladder cancer
por: Khan, Mairah T., et al.
Publicado: (2021)

Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata
por: Woll, Penella J., et al.
Publicado: (2023)

Enhanced stability of microRNA expression facilitates classification of FFPE tumour samples exhibiting near total mRNA degradation
por: Hall, J S, et al.
Publicado: (2012)

Expression of miR-210 in relation to other measures of hypoxia and prediction of benefit from hypoxia modification in patients with bladder cancer
por: Irlam-Jones, J J, et al.
Publicado: (2016)

The predictive and prognostic value of tumour necrosis in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 trial (CRUK/01/004)
por: Choudhury, Ananya, et al.
Publicado: (2017)

Exon-array profiling unlocks clinically and biologically relevant gene signatures from formalin-fixed paraffin-embedded tumour samples
por: Hall, J S, et al.
Publicado: (2011)

Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial()
por: Eustace, Amanda, et al.
Publicado: (2013)

Precision medicine in cancer: challenges and recommendations from an EU-funded cervical cancer biobanking study
por: Samuels, Sanne, et al.
Publicado: (2016)

Feasibility and acceptability of breath research in primary care: a prospective, cross-sectional, observational study
por: Woodfield, Georgia, et al.
Publicado: (2021)

Feasibility of a multiparametric MRI protocol for imaging biomarkers associated with neoadjuvant radiotherapy for soft tissue sarcoma
por: Kershaw, Lucy, et al.
Publicado: (2021)

Carbonic Anhydrase IX (CAIX), Cancer, and Radiation Responsiveness
por: Ward, Carol, et al.
Publicado: (2018)

Prediction of prostate tumour hypoxia using pre-treatment MRI-derived radiomics: preliminary findings
por: Zhong, Jim, et al.
Publicado: (2023)

Expression of transmembrane carbonic anhydrases, CAIX and CAXII, in human development
por: Liao, Shu-Yuan, et al.
Publicado: (2009)

The Expression of Glut-1, CAIX, and MCT4 in Mucinous Carcinoma
por: Kim, Sewha, et al.
Publicado: (2013)

Levamisole-adulterated Cocaine Induced Vasculitis with Skin Ulcerations
por: Pillow, Malford T., et al.
Publicado: (2013)

Investigation of the Prognostic Role of Carbonic Anhydrase 9 (CAIX) of the Cellular mRNA/Protein Level or Soluble CAIX Protein in Patients with Oral Squamous Cell Carcinoma
por: Eckert, Alexander W., et al.
Publicado: (2019)

Hemorrhagic Encephalopathy From Acute Baking Soda Ingestion
por: Hughes, Adrienne, et al.
Publicado: (2016)

Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis
por: Ward, D G, et al.
Publicado: (2006)

Identification of serum biomarkers for colon cancer by proteomic analysis
por: Ward, D G, et al.
Publicado: (2006)

The Sulfamate Small Molecule CAIX Inhibitor S4 Modulates Doxorubicin Efficacy
por: van Kuijk, Simon J. A., et al.
Publicado: (2016)

CAIX-targeting radiotracers for hypoxia imaging in head and neck cancer models
por: Huizing, Fokko J., et al.
Publicado: (2019)

Molecular Resonance Imaging of the CAIX Expression in Mouse Mammary Adenocarcinoma Cells
por: Quattrociocchi, Claudia, et al.
Publicado: (2023)

Delayed Diagnosis of Gastric Outlet Obstruction from Bouveret Syndrome in a Young Woman
por: Smith, Zachary, et al.
Publicado: (2015)

Dichloroacetate induces apoptosis and cell-cycle arrest in colorectal cancer cells
por: Madhok, B M, et al.
Publicado: (2010)

Upregulation of Claudin-4, CAIX and GLUT-1 in distant breast cancer metastases
por: Jiwa, Laura S, et al.
Publicado: (2014)

Expression of HIF-1α and CAIX in nasopharyngeal carcinoma and their correlation with patients’ prognosis
por: Chen, Yuhan, et al.
Publicado: (2014)

CAIX aptamer-functionalized targeted nanobubbles for ultrasound molecular imaging of various tumors
por: Zhu, Lianhua, et al.
Publicado: (2018)

Cu(ii)-BODIPY photosensitizer for CAIX overexpressed cancer stem cell therapy
por: Jung, Hyo Sung, et al.
Publicado: (2023)

Immunohistochemical discrimination of wild-type EGFR from EGFRvIII in fixed tumour specimens using anti-EGFR mAbs ICR9 and ICR10
por: Modjtahedi, H, et al.
Publicado: (2012)

Expression of phosphorylated eIF4E-binding protein 1, but not of eIF4E itself, predicts survival in male breast cancer
por: Millican-Slater, Rebecca A, et al.
Publicado: (2016)

Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multicentre, randomised, controlled phase II trial (NOURISH)
por: Pascoe, Jennifer, et al.
Publicado: (2021)

Pulmonary vein thrombosis in patients with medical risk factors
por: Stein, Paul D., et al.
Publicado: (2018)

Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas
por: Burrows, Natalie, et al.
Publicado: (2016)

Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer
por: Hussain, S A, et al.
Publicado: (2007)

Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting
por: Tiernan, J P, et al.
Publicado: (2013)

Diagnostic and mechanistic implications of serum free light chains, albumin and alpha-fetoprotein in hepatocellular carcinoma
por: Teng, M, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_v1gv3pmqug86te19jhgsnpseku